Furthermore, PKM2 contributes to the early diagnosis and prognosis assessment of CRC, with high expression associated with clinical features such as lymph node metastasis, tumor staging, and poor prognosis [52, 53, 54, 55]. This evidence concerns the gene PKM and neoplasm.